Hundreds of listeners tuned into our recent web seminar on Quality by Design, and we didn’t have time to answer all their questions. Fortunately, our speakers gathered to answer the common questions in this podcast. Listen to hear their views on questions such as:
• What are the differences in how QbD is applied to a biotech drug substance and drug product?
• Does QbD only make sense for big companies?
• How can companies make pre-approval and post approval process changes under QbD?
Click here for the full web seminar on Quality by Design.